Zepteon
Ronald Sia, Strategic Advisor, has served as an attorney for seven years at Procter & Gamble and Gillette. He has handled supporting a global $1 billion business and provided business guidance on innovation and commercial strategies across new products and base business initiatives. He has served as the lead attorney on multiple domestic and foreign disputes including advertising challenges and patent infringement cases. He has received a JD from UNH and a BS in chemical engineering from Tufts University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Zepteon
Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.